Join date: Feb 26, 2022

Rising research and development activities to cure or alleviate diseases such as cancer and other immunodeficiency ailments are driving the Recombinant DNA Technology Market. The success rate of genetically engineered human insulin in the treatment of diabetes has spurred the development of several other drugs, which is also fueling the market growth. The use of recombinant DNA technology to produce high-quality genetically modified crops is also boosting the market growth.

Read More:

Also Read: blockchain technology market, health insurance market, flat steel market

Jacob Willson
More actions